Page 97 - Eceptor News Today

Researchers identify and characterize the targets of Vit D on COVID-19 and osteoporosis.

Patients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer markers of immune cell exhaustion, and distinct changes to immune cell populations were more likely to have longer progression-free survival (PFS) after treatment with BCMA-targeted T-cell therapy.

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative.

Researchers performed a structural bioinformatics analysis to evaluate the binding energy of the SARS-CoV-2 Omicron variants of concern spike protein receptor-binding domain to human angiotensin-converting enzyme 2 receptor compared to other VOCs.

Researchers explored the activity of an ACE2 decoy against SARS-CoV-2 Omicron variant.

Breast tissue features apparent on MRI are linked with future second breast cancer risk in women with a personal history of breast cancer, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA).

Researchers evaluated pregnancy-specific responses to SARS-CoV-2 infection.

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

Researchers map the proteomes of peripheral blood neutrophils isolated from hospitalized COVID-19 patients using high-resolution LC-MS.

Researchers are exploring a potential new therapeutic approach for triple negative breast cancer treatment.